|
AUSTRALIA
Sydney
 Proteome
Systems is dedicated to the development of proteomics technology,
to the discovery of biomarkers and drug targets, and to proteomic
bioinformatics. Established in 1999, Proteome Systems has quickly
grown to become one of the world's major forces in proteomics. Proteome
Systems is headquartered in Sydney, Australia and has premises in
the Boston area in the United States. Both sites have more than
20,000 square feet of office and/or laboratory space. With over
70 staff, more than half which hold PhDs, Proteome Systems has developed
an integrated suite of novel technology to make the world's first
integrated, high-throughput platform for proteome analysis. This
platform, ProteomIQ™ currently deployed on a large scale in
the Sydney laboratories and soon to be deployed in many sites around
the world, is massively accelerating Proteome Systems' discovery
research. Proteome Systems Ltd is an Australian private company.
Its shareholders include its founders, senior management and other
private corporations.
|
